Skip to main content

Table 1 Patient characteristics

From: A scoring system predicting acute radiation dermatitis in patients with head and neck cancer treated with intensity-modulated radiotherapy

Age (years) 24–84 (median 67) 67)   
Sex
 Male 75     
 Female 26     
Tumor site
 Tongue 5     
 Gingiva 7     
 Nasopharynx 14     
 Oropharynx 34     
 Hypopharynx 24     
 Larynx 6     
 Nasal cavity 1     
 Paranasal sinuses 9     
 Unknown 1     
Histology
 Squamous cell carcinoma 99     
 Other 2     
TNM stage   N0 N1 N2 N3
T0–1 2 2 8 3
T2 9 3 23 3
T3 10 3 6 1
T4 5 5 18 0
Treatment
Neoadjuvant (+) 41     
Neoadjuvant (−) 60     
Concurrent (+) 78     
Concurrent (−) 23     
Radiation treatment
 IMRT-4X 46     
 VMAT-6X 55     
  1. Abbreviations: IMRT intensity modulated radiotherapy, VMAT volumetric modulated arc therapy
  2. Neoadjuvant therapy: TPF (Docetaxel, Cisplatin, 5-Fluorouracil), TPE (Docetaxel, Cisplatin, Cetuximab), FP (Cisplatin, 5-Fluorouracil), CDDP (Cisplatin), and CBDCA (Carboplatin)
  3. Adjuvant therapy: CDDP (Cisplatin), CBDCA (Carboplatin), and Cet (Cetuximab)